Michelle K. Rhee

Michelle K. Rhee

Auto-generated profile, based on publicly available information

Michelle K. Rhee

Department of Ophthalmology, Icahn School of Medicine at Mount Sinai, New York, NY, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2017 in Ophthalmology
Verified
Journal Article
Closed access
MRMichelle K. Rhee
Michelle K. Rhee
FMFrancis S. Mah
Francis S. Mah

13 February 2024 in Ophthalmology
Verified
Journal Article
Open access
MRMichelle K. Rhee
Michelle K. Rhee
SASumayya Ahmad
Sumayya Ahmad
GAGuillermo Amescua
Guillermo Amescua
ACAlbert Y. Cheung
Albert Y. Cheung
DCDaniel S. Choi
Daniel S. Choi
DVDivya M. Varu
Divya M. Varu

1 April 2019 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
DDDeepinder K Dhaliwal
Deepinder K Dhaliwal
SZSiwei Zhou
Siwei Zhou
SSSandeep S Samudre
Sandeep S Samudre
NLNathan J Lo
Nathan J Lo
MRMichelle K Rhee
Michelle K Rhee
Purpose: Dry eye disease (DED) is a common disorder that negatively impacts quality of life and vision. Prior studies have shown some benefit of acupuncture for dry eye, but very few have included control group to mitigate placebo effect. This study was designed with a sham acupuncture control group to evaluate true acupuncture treatment effect. Methods: This is a prospective, randomized, double-blinded, sham-acupuncture-controlled trial. Acupuncture treatment for dry eye was performed as per the Niemtzow Protocol. Twenty-four patients received true acupuncture and twenty-five received sham acupuncture. Treatment efficacy was assessed by the Ocular Surface Disease Index (OSDI) Questionnaire, ocular surface staining, tear flow, tear film break-up time (TBUT), and a general questionnaire. Atmospheric data were collected to control for the effect of atmospheric conditions on symptoms of dry eye. Results: OSDI scores in the treatment group improved compared to baseline (1 week, p<0.01, 1 month p<0.05, 3 months p<0.05, and 6 months p<0.01). OSDI scores in the control group improved, but did not reach significance (p=0.09). Secondary outcome measures showed no significant improvement in TBUT, Schiermer’s Test, ocular surface grading, or artificial tear application. However, at 3 months, a significant reduction in the frequency of eye closing was observed among participants receiving true acupuncture treatment when compared to baseline (p=0.002). Furthermore, intragroup analysis showed significant reduction in symptoms of discomfort (p=0.01), dryness (p=0.001), scratchiness (p=0.001), and redness (p=0.01) in the true acupuncture group at 3 months. Conclusion: Both true and sham acupuncture improved OSDI at 1 week after treatment, however, the improvement in OSDI was significantly greater in the true treatment groups than the sham group at 6 months after acupuncture. True acupuncture treatment improved many subjective assessments of dry eye symptoms, however, other common indicators used to objectively assess dry eye (tear flow, corneal staining, TBUT) remained unchanged. While there were trends towards improvement in the sham acupuncture group, this did not reach statistical significant during the study period. This suggests a true treatment effect of acupuncture rather than a placebo effect. Acupuncture can, therefore, be an effective adjunct to routine clinical treatment of dry eye.

1 June 2017 in Clinical Ophthalmology
Verified
Journal Article
Open access
PDF file
MRMichelle K Rhee
Michelle K Rhee
FMFrancis S Mah
Francis S Mah
To review the literature on the efficacy of cyclosporine (CsA) ophthalmic emulsion 0.05% on symptomatic relief in chronic dry eye disease. There is consistent evidence of objective improvements in chronic dry eye disease (Schirmer score, corneal and interpalpebral dye staining, and tear breakup time) with CsA, but variable results with symptomatic improvement, possibly due to patient tolerance of CsA, similar comforting effect with artificial tears and CsA vehicle, and the inherent subjective nature of symptom monitoring and analysis. This review explores the literature on CsA with special attention to symptomatic relief.

21 April 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
BBBryana Banashefski
Bryana Banashefski
MRMichelle K. Rhee
Michelle K. Rhee
GLGareth Lema
Gareth Lema
High myopia is a significant public health issue globally and in the United States (US), where it affects ~4% of the population or 13 million people. This is a potentially blinding condition, but complications can be prevented with early intervention in childhood. Several countries have developed robust data on high myopia, but the United States' data on high myopia remains lacking. Further, underrepresented populations are at particular risk of complications due to reduced access to optometric and ophthalmic care. We performed a systematic scoping review of population-based studies that investigated the prevalence of high myopia across racial and ethnic groups in the US to identify the impact of high myopia on underrepresented communities. Only four studies were identified that met inclusion criteria, which highlights the need to further investigate the topic in the United States. The prevalence of high myopia ranged from a low of 1.8% among Hispanic populations to a high of 11.8% among Chinese populations. Our study demonstrated a paucity of high myopia data in the United States and variable rates of high myopia depending on the time and location of each study. More complete prevalence data will help identify opportunities for community-based interventions to prevent debilitating and blinding complications of high myopia.

1 January 2016 in International Ophthalmology Clinics
Verified
Journal Article
Closed access
MRMichelle K. Rhee
Michelle K. Rhee
FMfrancis mah
francis mah